Plus Tx has co,bined image-guided local beta radiation and targeted drug delivery approaches to advance a pipeline of product candidates with lead programs in recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). 

The company is headquartered in Austin, Texas, with additional laboratories and state-of-the-art clean rooms in San Antonio, Texas in order to undertake key development, manufacturing, and preclinical activities..